AIDS-related Kaposi sarcoma, version 2.2019

Erin Reid; Gita Suneja; Richard F. Ambinder; Kevin Ard; Robert Baiocchi; Stefan K. Barta; Evie Carchman; Adam Cohen; Oxana V. Crysler; Neel Gupta; Chelsea Gustafson; Allison Hall; Kimberly L. Johung; Ann Klopp; Ann S. LaCasce; Chi Lin; Amitkumar Mehta; Manoj P. Menon; David Morgan; Nitya Nathwani; Ariela Noy; Lee Ratner; Stacey Rizza; Michelle A. Rudek; Julian Sanchez; Jeff Taylor; Benjamin Tomlinson; Chia Ching J. Wang; Sai Yendamuri; Mary A. Dwyer; Deborah A. Freedman-Cass

doi:10.6004/jnccn.2019.0008

AIDS-related Kaposi sarcoma, version 2.2019

Erin Reid
, Gita Suneja
, Richard F. Ambinder
, Kevin Ard
, Robert Baiocchi
, Stefan K. Barta
, Evie Carchman
, Adam Cohen
, Oxana V. Crysler
, Neel Gupta
, Chelsea Gustafson
, Allison Hall
, Kimberly L. Johung
, Ann Klopp
, Ann S. LaCasce
, Chi Lin
, Amitkumar Mehta
, Manoj P. Menon
, David Morgan
, Nitya Nathwani

Ariela Noy, Lee Ratner, Stacey Rizza, Michelle A. Rudek, Julian Sanchez, Jeff Taylor, Benjamin Tomlinson, Chia Ching J. Wang, Sai Yendamuri, Mary A. Dwyer, Deborah A. Freedman-Cass

Research output: Contribution to journal › Article › peer-review

47 Scopus citations

Abstract

As treatment of HIV has improved, people living with HIV (PLWH) have experienced a decreased risk of AIDS and AIDS-defining cancers (non-Hodgkin’s lymphoma, Kaposi sarcoma, and cervical cancer), but the risk of Kaposi sarcoma in PLWH is still elevated about 500-fold compared with the general population in the United States. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AIDS-Related Kaposi Sarcoma provide diagnosis, treatment, and surveillance recommendations for PLWH who develop limited cutaneous Kaposi sarcoma and for those with advanced cutaneous, oral, visceral, or nodal disease.

Original language	English
Pages (from-to)	171-189
Number of pages	19
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	17
Issue number	2
DOIs	https://doi.org/10.6004/jnccn.2019.0008
State	Published - Feb 2019

Access to Document

10.6004/jnccn.2019.0008

Cite this

Reid, E., Suneja, G., Ambinder, R. F., Ard, K., Baiocchi, R., Barta, S. K., Carchman, E., Cohen, A., Crysler, O. V., Gupta, N., Gustafson, C., Hall, A., Johung, K. L., Klopp, A., LaCasce, A. S., Lin, C., Mehta, A., Menon, M. P., Morgan, D., ... Freedman-Cass, D. A. (2019). AIDS-related Kaposi sarcoma, version 2.2019. JNCCN Journal of the National Comprehensive Cancer Network, 17(2), 171-189. https://doi.org/10.6004/jnccn.2019.0008

@article{a21f2e795f7746fcac0a073349908a8c,

title = "AIDS-related Kaposi sarcoma, version 2.2019",

abstract = "As treatment of HIV has improved, people living with HIV (PLWH) have experienced a decreased risk of AIDS and AIDS-defining cancers (non-Hodgkin{\textquoteright}s lymphoma, Kaposi sarcoma, and cervical cancer), but the risk of Kaposi sarcoma in PLWH is still elevated about 500-fold compared with the general population in the United States. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AIDS-Related Kaposi Sarcoma provide diagnosis, treatment, and surveillance recommendations for PLWH who develop limited cutaneous Kaposi sarcoma and for those with advanced cutaneous, oral, visceral, or nodal disease.",

author = "Erin Reid and Gita Suneja and Ambinder, \{Richard F.\} and Kevin Ard and Robert Baiocchi and Barta, \{Stefan K.\} and Evie Carchman and Adam Cohen and Crysler, \{Oxana V.\} and Neel Gupta and Chelsea Gustafson and Allison Hall and Johung, \{Kimberly L.\} and Ann Klopp and LaCasce, \{Ann S.\} and Chi Lin and Amitkumar Mehta and Menon, \{Manoj P.\} and David Morgan and Nitya Nathwani and Ariela Noy and Lee Ratner and Stacey Rizza and Rudek, \{Michelle A.\} and Julian Sanchez and Jeff Taylor and Benjamin Tomlinson and Wang, \{Chia Ching J.\} and Sai Yendamuri and Dwyer, \{Mary A.\} and Freedman-Cass, \{Deborah A.\}",

note = "Publisher Copyright: {\textcopyright} JNCCN—Journal of the National Comprehensive Cancer Network",

year = "2019",

month = feb,

doi = "10.6004/jnccn.2019.0008",

language = "English",

volume = "17",

pages = "171--189",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

number = "2",

}

Reid, E, Suneja, G, Ambinder, RF, Ard, K, Baiocchi, R, Barta, SK, Carchman, E, Cohen, A, Crysler, OV, Gupta, N, Gustafson, C, Hall, A, Johung, KL, Klopp, A, LaCasce, AS, Lin, C, Mehta, A, Menon, MP, Morgan, D, Nathwani, N, Noy, A, Ratner, L, Rizza, S, Rudek, MA, Sanchez, J, Taylor, J, Tomlinson, B, Wang, CCJ, Yendamuri, S, Dwyer, MA & Freedman-Cass, DA 2019, 'AIDS-related Kaposi sarcoma, version 2.2019', JNCCN Journal of the National Comprehensive Cancer Network, vol. 17, no. 2, pp. 171-189. https://doi.org/10.6004/jnccn.2019.0008

TY - JOUR

T1 - AIDS-related Kaposi sarcoma, version 2.2019

AU - Reid, Erin

AU - Suneja, Gita

AU - Ambinder, Richard F.

AU - Ard, Kevin

AU - Baiocchi, Robert

AU - Barta, Stefan K.

AU - Carchman, Evie

AU - Cohen, Adam

AU - Crysler, Oxana V.

AU - Gupta, Neel

AU - Gustafson, Chelsea

AU - Hall, Allison

AU - Johung, Kimberly L.

AU - Klopp, Ann

AU - LaCasce, Ann S.

AU - Lin, Chi

AU - Mehta, Amitkumar

AU - Menon, Manoj P.

AU - Morgan, David

AU - Nathwani, Nitya

AU - Noy, Ariela

AU - Ratner, Lee

AU - Rizza, Stacey

AU - Rudek, Michelle A.

AU - Sanchez, Julian

AU - Taylor, Jeff

AU - Tomlinson, Benjamin

AU - Wang, Chia Ching J.

AU - Yendamuri, Sai

AU - Dwyer, Mary A.

AU - Freedman-Cass, Deborah A.

PY - 2019/2

Y1 - 2019/2

N2 - As treatment of HIV has improved, people living with HIV (PLWH) have experienced a decreased risk of AIDS and AIDS-defining cancers (non-Hodgkin’s lymphoma, Kaposi sarcoma, and cervical cancer), but the risk of Kaposi sarcoma in PLWH is still elevated about 500-fold compared with the general population in the United States. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AIDS-Related Kaposi Sarcoma provide diagnosis, treatment, and surveillance recommendations for PLWH who develop limited cutaneous Kaposi sarcoma and for those with advanced cutaneous, oral, visceral, or nodal disease.

AB - As treatment of HIV has improved, people living with HIV (PLWH) have experienced a decreased risk of AIDS and AIDS-defining cancers (non-Hodgkin’s lymphoma, Kaposi sarcoma, and cervical cancer), but the risk of Kaposi sarcoma in PLWH is still elevated about 500-fold compared with the general population in the United States. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AIDS-Related Kaposi Sarcoma provide diagnosis, treatment, and surveillance recommendations for PLWH who develop limited cutaneous Kaposi sarcoma and for those with advanced cutaneous, oral, visceral, or nodal disease.

UR - https://www.scopus.com/pages/publications/85061988451

U2 - 10.6004/jnccn.2019.0008

DO - 10.6004/jnccn.2019.0008

M3 - Article

C2 - 30787130

AN - SCOPUS:85061988451

SN - 1540-1405

VL - 17

SP - 171

EP - 189

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 2

ER -

AIDS-related Kaposi sarcoma, version 2.2019

Abstract

Access to Document

Other files and links

Fingerprint

Cite this